BioCentury
ARTICLE | Company News

Pharmacyclics, Servier deal

May 2, 2011 7:00 AM UTC

Pharmacyclics received a $7 million milestone payment from Servier under a 2009 deal granting Servier exclusive, ex-U.S. rights to develop and commercialize PCI-24781/S 78454. The payment was trigger...